Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Top Cited Papers
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9227) , 385-390
- https://doi.org/10.1016/s0140-6736(00)02530-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Mortality studies in psoriatic arthritis. Results from a single outpatient clinic. I. Causes and risk of deathArthritis & Rheumatism, 1997
- Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative studyArthritis & Rheumatism, 1996
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesionsClinical and Experimental Immunology, 1994
- PSORIATIC ARTHRITIS (PA): A CLINICAL, IMMUNOLOGICAL AND RADIOLOGICAL STUDY OF 180 PATIENTSRheumatology, 1991
- A MULTICENTRE DOUBLE-BLIND COMPARISON OF AURANOFIN, INTRAMUSCULAR GOLD THIOMALATE AND PLACEBO IN PATIENTS WITH PSORIATIC ARTHRITISRheumatology, 1990
- SULPHASALAZINE IN PSORIATIC ARTHRITIS: A DOUBLE-BLIND PLACEBO-CONTROLLED STUDYRheumatology, 1990
- Randomized, Double‐Blind, Placebo Controlled Trial of Low‐Dose Pulse Methotrexate in Psoriatic ArthritisArthritis & Rheumatism, 1984
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978
- THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITYThe Lancet Healthy Longevity, 1951